Literature DB >> 33065557

Exhaled breath condensate biomarkers in critically ill, mechanically ventilated patients.

Michael D Davis1, Brett R Winters2, Michael C Madden3, Joachim D Pleil4, Curtis N Sessler5, M Ariel Geer Wallace6, Cavin K Ward-Caviness3, Alison J Montpetit7.   

Abstract

Pneumonia is a significant risk for critically ill, mechanically ventilated (CIMV) patients. Diagnosis of pneumonia generally requires a combination of clinician-guided diagnoses and clinical scoring systems. Exhaled breath condensate (EBC) can be safely collected non-invasively from CIMV patients. Hundreds of biomarkers in EBC are associated with acute disease states, including pneumonia. We evaluated cytokines in EBC from CIMV patients and hypothesized that these biomarkers would correlate with disease severity in pneumonia, sepsis, and death. EBC IL-2 levels were associated with chest radiograph severity scores (odds ratio = 1.68; 95% confidence interval = 1.09-2.60; P = 0.02). EBC TNF-α levels were also associated with pneumonia (odds ratio = 3.20; 95% confidence interval = 1.19-8.65; P = 0.02). The techniques and results from this study may be useful for all mechanically ventilated patients.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33065557      PMCID: PMC9003134          DOI: 10.1088/1752-7163/abc235

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  35 in total

1.  Tumor necrosis factor-alpha and interleukin-6 profiles in children with pneumonia.

Authors:  C M Wang; R B Tang; R L Chung; B T Hwang
Journal:  J Microbiol Immunol Infect       Date:  1999-12       Impact factor: 4.399

2.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

Review 3.  Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review.

Authors:  Petr Kubáň; František Foret
Journal:  Anal Chim Acta       Date:  2013-07-31       Impact factor: 6.558

Review 4.  Exhaled Breath Condensate: An Update.

Authors:  Michael D Davis; Alison J Montpetit
Journal:  Immunol Allergy Clin North Am       Date:  2018-09-21       Impact factor: 3.479

Review 5.  Exhaled breath condensate collection in the mechanically ventilated patient.

Authors:  Stewart R Carter; Christopher S Davis; Elizabeth J Kovacs
Journal:  Respir Med       Date:  2012-03-06       Impact factor: 3.415

6.  The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group.

Authors:  D K Heyland; D J Cook; L Griffith; S P Keenan; C Brun-Buisson
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

7.  Exhaled-breath condensate pH can be safely and continuously monitored in mechanically ventilated patients.

Authors:  Brian K Walsh; Dan J Mackey; Thomas Pajewski; Yuanlin Yu; Benjamin M Gaston; John F Hunt
Journal:  Respir Care       Date:  2006-10       Impact factor: 2.258

8.  Sampling and analyzing alveolar exhaled breath condensate in mechanically ventilated patients: a feasibility study.

Authors:  Rosanna Vaschetto; Massimo Corradi; Matteo Goldoni; Laura Cancelliere; Simone Pulvirenti; Ugo Fazzini; Fabio Capuzzi; Federico Longhini; Antonio Mutti; Francesco Della Corte; Paolo Navalesi
Journal:  J Breath Res       Date:  2015-11-19       Impact factor: 3.262

9.  Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit.

Authors:  Canan BalcI; Hülya Sungurtekin; Ercan Gürses; Ugur Sungurtekin; Bünyamin Kaptanoglu
Journal:  Crit Care       Date:  2002-10-30       Impact factor: 9.097

Review 10.  Exhaled Breath Condensate: Technical and Diagnostic Aspects.

Authors:  Efstathia M Konstantinidi; Andreas S Lappas; Anna S Tzortzi; Panagiotis K Behrakis
Journal:  ScientificWorldJournal       Date:  2015-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.